Latest Investment News

Australian Foundation Investment Company (AFIC) announces the retirement of long-serving CEO Mark Freeman and the appointment of Alison Gibson as his successor, marking a significant leadership transition for the $12 billion investment firm.

Centrepoint Alliance reports a 17% rise in normalised EBITDA for H1 FY26 and announces a strategic divestment of its lending aggregation business to Astute Financial Management, expected to boost annual EBITDA by $0.4 million from FY27.

Medallion Metals has secured a US$50 million loan and a copper-gold concentrate offtake agreement with Trafigura, enabling the Final Investment Decision for the Ravensthorpe Gold Project. Development is set to begin pending completion of the Forrestania acquisition.

Lincoln Minerals is sharpening its focus on copper exploration with a renewed push at its Minbrie Project and new collaborations targeting base metals and graphite markets.

Viridis Mining and Minerals reports strong infill and exploration drilling results at its Colossus Rare Earth Element Project, underpinning a resource upgrade and enhanced project economics. The company advances feasibility, permitting, and financing towards a Final Investment Decision in Q3 2026.

Asset Vision has reported a robust 38% increase in annual recurring revenue to $5.2 million in the first half of FY26, underpinned by new council contracts and AI-driven platform upgrades. The company’s positive cash EBITDA and strategic focus on scalable growth signal strong momentum in the critical infrastructure SaaS market.

Asset Vision Co Limited reported a 27% increase in revenue to $3.06 million for the half-year ended December 2025, yet recorded a net loss of $54,052 due to deliberate investments in growth and product development.

Acrow Limited reaffirms its first half FY26 revenue guidance with a 22% increase year-on-year, driven by robust demand in key Australian regions and strategic capital investments.

MLG Oz Limited reported a robust HY2026 with statutory net profit after tax soaring 73.2% to $7.1 million, driven by strong demand in the gold sector and operational resilience despite early weather setbacks and a safety fine.

MLG Oz Limited has delivered a robust half-year performance with revenue climbing 6% and EBITDA soaring 24.5%, underpinned by strong gold sector demand and operational efficiencies.

MLG Oz Limited reported a robust half-year with revenue up 5.3% to $287.2 million and net profit soaring 73.3% to $7.1 million, overcoming early weather disruptions and a significant safety fine.

Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.